Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
Change company Symbol lookup
Select an option...
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FR First Industrial Realty Trust Inc
PNI PIMCO New York Municipal Income Fund II
NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Closing Price
$0.76
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.78
Day's Low
0.5088
Volume
(Above Average)
Volume:
1,592

10-day average volume:
1,592
1,592

Shorting crypto stocks has led to 'substantial' paper gains, but it's getting harder to join in on the trend

11:06 am ET June 15, 2022 (MarketWatch)
Print

By Emily Bary

Crypto shorts were up 126% on the year through Tuesday's session, per S3 Partners

The short selling of cryptocurrency-related stocks has yielded "substantial" mark-to-market profits this year, but those looking to get in on the action may have more trouble doing so going forward.

Short sellers in a basket of 15 crypto stocks including Coinbase Global Inc. (COIN), MicroStrategy Inc. (MSTR), and crypto miners like Marathon Digital Holdings Inc. (MARA), have racked up paper gains of 126% year to date through Tuesday's session, according to Ihor Dusaniwsky, the managing director of predictive analytics at S3 Partners.

In June alone, crypto shorts are up 42%, and have notched paper profits of 16% just based on Tuesday's activity, which saw cryptocurrency stocks come under further pressure amid falling prices for digital assets and a layoff announcement from Coinbase.

See also: Why Coinbase is laying off 18% of employees and what it means for crypto

Bitcoin , which dropped 3.8% in morning trading Wednesday toward an 18-month low, has tumbled 33.1% in June and plunged 54.1% this year.

Dusaniwsky noted that interest in crypto short selling has been growing, and he cited $71 million of new shorting in less than two weeks of June.

"But with the pool of stock borrows in these names limited, due to lack of sizable ownership in the funds of the largest and most active stock lenders on the street, prospective short sellers may be late to the party," he continued in a report. "While the crypto stocks' negative price momentum may not be over, the ability to short stock in size may be over."

Dusaniwsky pointed to 91% stock-borrow utilization in crypto names. "There is some stock available to borrow to cover short sales," he noted, but " short sales in size will be difficult to execute and stock borrow rates will be getting more expensive for both new and existing short sales."

Read: Half of bitcoin holders on Coinbase exchange may face losses, Mizuho says

Stock-borrow trends make it so "short exposure in these stocks will not increase dramatically in the future," he wrote, meaning that "shorting these stocks will become more expensive and take a bigger bite out of expected alpha." As such, he expects that continued drops in crypto stocks would be the result of longs, not shorts, selling their shares. .

Should crypto stocks rally, Dusaniwsky anticipates "a flurry of buy-to-covers as short sellers look to realize their substantial profits." He added that "[s]hort sellers should not be blamed for near term downward price moves, but they may be an active participant in future rallies."

-Emily Bary

	

(END) Dow Jones Newswires

June 15, 2022 11:06 ET (15:06 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.